Indanorex
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
  | 
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H17NO | 
| Molar mass | 191.274 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
| (verify) | |
Indanorex (Dietor) is a stimulant drug which was developed in the 1970s.[1][2] It has appetite suppressant effects and also has antihypoglycemia effects.[3]
A chemical synthesis has been reported.[4]
See also
References
- ↑ Jacques Georges Maillard, U.S. patent 3,885,045 (1975 to Logeais Labor Jacques).
 - ↑ FR 2322851 (1977 to Logeais Labor Jacques).
 - ↑ Giugliano D, Luyckx A, Binder D, Lefebvre P (February 1979). "Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia". International Journal of Clinical Pharmacology and Biopharmacy. 17 (2): 76–81. PMID 422305.
 - ↑ Maillard, J. et al, Bull. Soc. Chim. Fr., 1967, 2110.
 
| DRAsTooltip Dopamine releasing agents | 
  | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRAsTooltip Norepinephrine releasing agents | 
  | ||||||||||||||
| SRAsTooltip Serotonin releasing agents | 
  | ||||||||||||||
| Others | 
 
  | ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins  | |||||||||||||||
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
